Medication info
Hibis Tablet

Hibis Tablet

Prescription medicationTabletOral
Ingredient · strength
Ranitidine Hydrochloride›168mg / 1 tabletTripotassium Bismuth Dicitrate›200mg / 1 tabletSucralfate Hydrate›600mg / 1 tablet
Manufacturer / importer
McNuity Pharmaceutical Co., Ltd.
Appearance
Green, rectangular, film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201604891 · Approved 2016.08.10

Summary

Main use
Treatment of acid-related disorders (e.g., ulcers, gastritis, reflux esophagitis); prevention of Mendelson's syndrome
Who takes it
Adults
Adult dose
Usually, take 1 tablet orally twice daily, in the morning and at bedtime, regardless of meals. Gastric and duodenal ulcers: Take 1 tablet twice daily, or 2 tablets once daily at bedtime. A higher cure rate may be achieved, particularly in patients with duodenal ulcers, by taking 2 tablets twice daily, in the morning and at bedtime. The same dosage applies to combination therapy for ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs) or for the prevention of gastric and duodenal ulcers during long-term NSAID treatment. NSAID-induced conditions usually heal within 4 weeks, and ulcers usually heal within 8 weeks, although healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 1 tablet once daily at bedtime as maintenance therapy. Gastroesophageal reflux disease: Take 1 tablet twice daily or 2 tablets once daily at bedtime for 8 weeks. In patients with severe gastroesophageal reflux disease, the dose may be increased to 2 tablets 4 times daily. Zollinger-Ellison syndrome: Initiate treatment with 1 tablet 3 times daily as the initial dose, and increase the dose as needed. In severe cases, up to 6 g of ranitidine daily may be administered as directed by a physician. Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions: When oral administration becomes possible, switch from injection to oral administration and give 1 tablet twice daily. Preanesthetic medication (prevention of Mendelson syndrome): Administer 1 tablet 2 hours before induction of anesthesia. It is also preferable to administer 1 tablet on the night before surgery.

Ingredients

Manufacturer
McNuity Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (e.g., ulcers, gastritis, reflux esophagitis); prevention of Mendelson's syndrome

  • Gastric and duodenal ulcers
  • gastritis
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson's syndrome
  • post-surgical ulcers
  • gastric/duodenal ulcers caused by nonsteroidal anti-inflammatory drugs
View approved original text

This medication is used to treat ulcers in the stomach and duodenum, gastritis, and gastroesophageal reflux disease. It is also effective for conditions caused by excessive gastric acid secretion, such as Zollinger-Ellison syndrome. It is applicable for the treatment of ulcers that may occur post-surgery and gastric/duodenal ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs). It can also be administered prior to anesthesia to prevent Mendelson's syndrome. This drug helps in the treatment of various gastrointestinal-related diseases.

How to take

Adult dose

Usually, take 1 tablet orally twice daily, in the morning and at bedtime, regardless of meals. Gastric and duodenal ulcers: Take 1 tablet twice daily, or 2 tablets once daily at bedtime. A higher cure rate may be achieved, particularly in patients with duodenal ulcers, by taking 2 tablets twice daily, in the morning and at bedtime. The same dosage applies to combination therapy for ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs) or for the prevention of gastric and duodenal ulcers during long-term NSAID treatment. NSAID-induced conditions usually heal within 4 weeks, and ulcers usually heal within 8 weeks, although healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 1 tablet once daily at bedtime as maintenance therapy. Gastroesophageal reflux disease: Take 1 tablet twice daily or 2 tablets once daily at bedtime for 8 weeks. In patients with severe gastroesophageal reflux disease, the dose may be increased to 2 tablets 4 times daily. Zollinger-Ellison syndrome: Initiate treatment with 1 tablet 3 times daily as the initial dose, and increase the dose as needed. In severe cases, up to 6 g of ranitidine daily may be administered as directed by a physician. Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions: When oral administration becomes possible, switch from injection to oral administration and give 1 tablet twice daily. Preanesthetic medication (prevention of Mendelson syndrome): Administer 1 tablet 2 hours before induction of anesthesia. It is also preferable to administer 1 tablet on the night before surgery.

Precautions

This medication should not be used in patients undergoing dialysis or those with impaired renal function. Additionally, patients who have previously experienced allergic reactions to this medication or its ingredients should avoid taking it. Patients with a rare condition known as acute porphyria should be cautious as this medication may exacerbate symptoms. It is safest not to administer this medication to patients who have undergone upper gastrointestinal surgery, pregnant women or those who may become pregnant, and premature or newborn infants. Patients on a dietary regimen that restricts potassium intake should also avoid taking this medication. Patients with poor liver function or a history of drug allergies, elderly patients, or those who have had prior kidney function issues should use this medication carefully. Regular monitoring is necessary when taken with nonsteroidal anti-inflammatory drugs due to the increased risk of gastrointestinal side effects. As this medication can mask symptoms of stomach cancer, patients with gastric ulcers or those over middle age who have newly developed or altered symptoms of indigestion must confirm the malignancy status before treatment. Patients with gastric or duodenal ulcers affected by Helicobacter pylori must undergo bacterial eradication therapy. Caution is required when administering to severely ill patients in intensive care, those with hypophosphatemia, or those with swallowing difficulties. During the use of this medication, rare but serious allergic reactions, blood abnormalities, liver function abnormalities, heart arrhythmias, gastrointestinal discomfort, and neurological symptoms may occur, requiring immediate consultation with medical personnel upon symptom onset. Do not use for extended periods, and monitor therapy closely while administering the minimal effective dose. Elderly patients or those with chronic pulmonary diseases, diabetes, or weakened immunity should be particularly cautious as the risk of pneumonia may increase. If dizziness or drowsiness occurs while taking this medication, it is advisable to avoid driving or operating hazardous machinery. There may be drug interactions; thus, especially when co-administered with anticoagulants, antibiotics, or anticonvulsants, notify healthcare providers. Pregnant or breastfeeding women should avoid taking this medication for safety. It is recommended not to use in children as safety and effectiveness have not been adequately established. In the case of overdose, emergency measures such as vomiting or gastric lavage may be necessary; in severe cases, blood dialysis can be used for removal. This medication decreases gastric acid secretion, which may promote bacterial growth in the stomach, hence, regular check-ups, including ophthalmic examinations, are necessary for long-term use.

Side effects

  • Anaphylactic shock
  • skin rash
  • urticaria
  • angioedema
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • leukopenia
Show 58 more
  • thrombocytopenia
  • elevated serum creatinine
  • elevated serum aminotransferases
  • agranulocytosis
  • pancytopenia
  • myelodysplasia
  • aplastic anemia
  • acquired immune hemolytic anemia
  • eosinophilia
  • elevated AST
  • elevated ALT
  • elevated r-GTP
  • elevated ALP
  • jaundiced hepatitis
  • non-jaundiced hepatitis
  • tachycardia
  • bradycardia
  • atrioventricular block
  • premature ventricular contraction
  • arrhythmia
  • vasculitis
  • nausea
  • vomiting
  • constipation
  • diarrhea
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • dizziness
  • drowsiness
  • confusional state
  • convulsions
  • agitation
  • insomnia
  • headache
  • heaviness in the head
  • illness sensation
  • anxiety
  • mental confusion
  • depression
  • hallucinations
  • blurred vision
  • involuntary movement disorder
  • consciousness disturbance
  • hepatic myoclonus
  • gynecomastia
  • hyperprolactinemia
  • erectile dysfunction
  • decreased libido
  • joint pain
  • myalgia
  • rhabdomyolysis
  • alopecia
  • glossitis
  • pruritus
  • mucous membrane syndrome
  • toxic epidermal necrolysis
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air and kept at room temperature between 1 to 30 degrees Celsius. Storing under these conditions will help maintain the medication's effectiveness for a longer duration.

Appearance and packaging

Appearance

Green, rectangular, film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.